Environmental Protection Agency announced today that they will fail.

Long-awaited EPA delay in fixing a Protective National Ambient Air Quality Standard for ozoneThe American Lung Association is extremely disappointed that the U.S. Environmental Protection Agency announced today that they will fail, set the date before the adoption a more protective national meet air quality standards for ozone. EPA said the U.S. Court of Appeals for the DC Circuit that come long-awaited decision until the end of October, two months after the deadline.

###Reference: Wang GQ, Cheng DS. Prevention treatment of gastrointestinal disorders after severe burn: A summary of the most recent 30 years of clinical experience. World J Gastroenterol 2008; 14 : 3231-3235.‘With these results , we believe we can to introduce the promise by genomics in clinical practice for colorectal cancer in breast for breast cancer, and are pleased that the study for the presentation at the upcoming ASCO Annual Meeting of in Orlando, Florida has been accepted. ‘.. Predict provisional results in QUASAR validation study of Oncotype DX Colon Cancer Assay.

Whilst meet its primary endpoint in the prediction of recurrences, that studies no fulfill a second end evaluating a separately visitors, with a significant set of genes, designed to predict cancer-related deaths greater relative advantages 5-fluorouracil/leucovorin after surgery. – ‘positive results of this positive results of this big QUASAR validation study for is an important step forwardly to a better understanding which biology on a disease which out of of cancer-related deaths,’said Steve Shak , chief medical officer by Genomic Health.

Genomic Health disclaims any obligation to update any such forward-looking statements.. This press release contains forward looking statements under the Private Securities Litigation Act of 1995, including the statements relating to applicability of clinical study results on actual results and to the Company’s intentions, the the Oncotype DX colon cancer Recurrence Score take be available doctor and patients in early 2010. Forward-looking statements are subject risks and uncertainties that cause actual figures to differ considerably, and reported outcomes should not be will be previewed as an indication of of future results.